CLINICAL TRIAL OF CLOMIPHENE IN ADVANCED BREAST-CANCER

被引:42
作者
HECKER, E [1 ]
VEGH, I [1 ]
LEVY, CM [1 ]
MAGIN, CA [1 ]
MARTINEZ, JC [1 ]
LOUREIRO, J [1 ]
GAROLA, RE [1 ]
机构
[1] UNIV BUENOS AIRES, INST ONCOL ANGEL H ROFFO, SECCION ENDOCRINOL, AVE SAN MARTIN 5481, BUENOS AIRES, ARGENTINA
关键词
D O I
10.1016/0014-2964(74)90114-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:747 / 749
页数:3
相关论文
共 17 条
[1]  
ATKINS H, 1968, LANCET, V2, P1261
[2]   ESTROGEN RECEPTOR - ANTIESTROGEN COMPLEX - ATYPICAL BINDING BY UTERINE NUCLEI AND EFFECTS ON UTERINE GROWTH [J].
CLARK, JH ;
ANDERSON, JN ;
PECK, EJ .
STEROIDS, 1973, 22 (05) :707-718
[3]   NEW ANTI-OESTROGENIC AGENT IN LATE BREAST CANCER - EARLY CLINICAL APPRAISAL OF ICI46474 [J].
COLE, MP ;
JONES, CTA ;
TODD, IDH .
BRITISH JOURNAL OF CANCER, 1971, 25 (02) :270-&
[4]  
GEYNET C, 1972, GYNECOL OBSTET INVES, V3, P2
[5]   ESTROGEN RECEPTORS IN HUMAN BREAST-CANCER .2. IN-VITRO BINDING OF ESTRADIOL BY BENIGN AND MALIGNANT TUMORS [J].
HAHNEL, R ;
TWADDLE, E ;
VIVIAN, AB .
STEROIDS, 1971, 18 (06) :681-&
[6]  
HERBST AL, 1964, CANCER CHEMOTH REP, P39
[7]   INHIBITION OF DMBA-INDUCED MAMMARY CARCINOGENESIS IN RAT BY 2-BR-ALPHA-ERGOCRYPTINE (CB 154), AN INHIBITOR OF PROLACTIN SECRETION, AND BBY NAFOXIDINE (U-11, 100A), AN ESTROGEN ANTAGONIST [J].
HEUSON, JC ;
WAELBROE.C ;
LEGROS, N ;
GALLEZ, G ;
ROBYN, C ;
LHERMITE, M .
GYNECOLOGIC INVESTIGATION, 1972, 2 (1-6) :130-137
[8]  
JENSEN EV, 1971, NATL CANCER I MONOGR, P55
[9]  
KENNEDY BJ, 1965, CANCER, V18, P1551, DOI 10.1002/1097-0142(196512)18:12<1551::AID-CNCR2820181206>3.0.CO
[10]  
2-1